Deutsche Bank Aktiengesellschaft Lowers CME Group (NASDAQ:CME) Price Target to $322.00

CME Group (NASDAQ:CME) had its target price reduced by investment analysts at Deutsche Bank Aktiengesellschaft from $342.00 to $322.00 in a research note issued to investors on Thursday,MarketScreener reports. The firm currently has a “buy” rating on the financial services provider’s stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 12.97% from the company’s previous close.

A number of other equities research analysts also recently weighed in on CME. Raymond James Financial boosted their target price on CME Group from $310.00 to $320.00 and gave the stock an “outperform” rating in a research report on Monday, April 6th. TD Cowen decreased their price objective on CME Group from $340.00 to $323.00 and set a “buy” rating for the company in a research note on Thursday. Keefe, Bruyette & Woods began coverage on CME Group in a research note on Wednesday, April 8th. They set a “market perform” rating and a $305.00 price objective for the company. Rothschild & Co Redburn decreased their price objective on CME Group from $347.00 to $340.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Finally, Erste Group Bank raised CME Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, March 5th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, CME Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $306.71.

CME Group Trading Down 0.2%

CME stock opened at $285.02 on Thursday. The company has a market cap of $102.22 billion, a P/E ratio of 24.32, a PEG ratio of 3.02 and a beta of 0.26. CME Group has a twelve month low of $257.17 and a twelve month high of $329.16. The company has a quick ratio of 1.03, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The business has a fifty day moving average of $304.51 and a 200-day moving average of $286.07.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.77 billion. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The firm’s quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.80 earnings per share. As a group, equities research analysts expect that CME Group will post 12.26 EPS for the current year.

Insider Buying and Selling

In related news, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total transaction of $1,300,530.00. Following the completion of the sale, the director directly owned 43,007 shares of the company’s stock, valued at $13,317,117.55. The trade was a 8.90% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Dennis Suskind sold 748 shares of CME Group stock in a transaction on Friday, February 6th. The stock was sold at an average price of $300.00, for a total value of $224,400.00. Following the sale, the director directly owned 2,699 shares of the company’s stock, valued at approximately $809,700. This trade represents a 21.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 8,539 shares of company stock valued at $2,713,821 in the last three months. 0.30% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CME Group

Large investors have recently modified their holdings of the business. Caldwell Trust Co boosted its position in shares of CME Group by 116.3% during the third quarter. Caldwell Trust Co now owns 93 shares of the financial services provider’s stock worth $25,000 after buying an additional 50 shares during the period. Asset Dedication LLC boosted its position in shares of CME Group by 64.9% during the fourth quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after buying an additional 37 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA acquired a new position in shares of CME Group during the third quarter worth about $27,000. FNY Investment Advisers LLC acquired a new position in shares of CME Group during the fourth quarter worth about $27,000. Finally, Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group during the fourth quarter worth about $27,000. 87.75% of the stock is currently owned by institutional investors.

More CME Group News

Here are the key news stories impacting CME Group this week:

• Positive Sentiment: Record Q1 revenue and volumes: CME reported record Q1 revenue and a surge in trading volumes, driven by higher hedging and risk-management activity — a core driver of futures and options trading revenue. Article Title
• Positive Sentiment: Earnings-call commentary backs the volume story: Management emphasized broad-based demand and rising market risk that is increasing hedging flows — a positive outlook for transaction-driven revenue. Article Title Article Title
• Positive Sentiment: Full earnings transcript available for deeper color: Investors can review management’s detail on volume drivers and segment performance. Article Title
• Neutral Sentiment: Multiple analysts trimmed price targets but kept constructive ratings: Deutsche Bank cut its PT to $322 (keeps buy) and TD Cowen cut to $323 (keeps buy); Morgan Stanley trimmed to $353 but retained overweight — these lower targets reflect model updates despite continued positive ratings. Article Title Article Title Article Title
• Neutral Sentiment: No meaningful short-interest signal: the short-interest data published for April is effectively zero/unchanged and does not explain the move. (No linked article.)
• Negative Sentiment: Goldman maintains a sell rating and lowered its PT to $267 — the most bearish big-bank view in the group and a direct negative for sentiment. Article Title
• Negative Sentiment: Mixed market reaction and some headline takes that Q1 sales missed analyst expectations or that the stock looks expensive post-earnings — these narratives can pressure short-term price action despite strong volume trends. Article Title Article Title

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.